NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025)
NovaBridge Biosciences (NBP) reported Cash from Financing Activities of $57.7 million for Q4 2025, up 1604.82% quarter-over-quarter from -$3.8 million in Q3 2024.
NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Cash from Financing Activities data on file, last reported at $57.7 million in Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $57.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $53.9 million (down 86.67% YoY), and the FY2025 annual result was $57.7 million, up 1483.96% from the prior year.
- Cash from Financing Activities improved to $57.7 million in Q4 2025 per NBP's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $57.7 million in Q4 2025 and troughed at -$3.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 85,464.43 |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 57.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.73 Mn |
| Dec 31, 2025 | 57.73 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Dec 31, 2019 | 16.07 Mn |
| Dec 31, 2019 | 16.07 Mn |